Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Filings indexed 454 across all filing types
Latest filing 2021-02-14 Regulatory Filings
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
Appendix 2A - issue of placement shares & cleansing notice 11 pages 446.5KB
Regulatory Filings Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It includes details about the entity, the type of securities being quoted, and references to previous announcements such as Appendix 3B. The document is a regulatory filing related to securities issuance and quotation, not a financial report, earnings release, or management discussion. It is a formal announcement to the exchange about securities quotation and related transactions. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2021-02-14 English
LGP secures firm commitments to raise $22 million 4 pages 907.6KB
Capital/Financing Update Classification · 100% confidence The document is an announcement dated 9 February 2021 from Little Green Pharma regarding a capital raising event. It details a $22 million placement of shares and a $5 million Share Purchase Plan (SPP) for existing shareholders. The text includes specifics about the issue price, discounts, timetable, and use of proceeds. There are no financial statements or detailed financial performance data included, only information about the fundraising and share issuance. This fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes. The document is not a full financial report, earnings release, or regulatory filing, but a clear announcement of a capital raise.
2021-02-08 English
Proposed issue of Securities - LGP 9 pages 37.5KB
Capital/Financing Update Classification · 100% confidence The document is an announcement from Little Green Pharma Ltd regarding a proposed issue of securities, including details about a securities purchase plan and a placement. It includes information such as the number of securities to be issued, offer price, record date, issue date, and conditions related to the offer. The content focuses on the company's capital raising activities and the terms of the securities issuance. There are no financial statements, earnings data, or management discussion of financial results. The document is not a report but an announcement about a capital raising event. Therefore, it fits the category of Capital/Financing Update (CAP). The document length and detail support a confident classification.
2021-02-08 English
Cleansing Notice 2 pages 220.6KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement titled 'Cleansing Notice' pursuant to paragraph 708A(5)(e) of the Corporations Act 2001. It notifies the market about the issue of shares without disclosure under Part 6D.2 of the Corporations Act and confirms compliance with relevant provisions. The document is short (3608 characters) and serves as a regulatory notice about share issuance and compliance, not a financial report or detailed analysis. It does not contain financial statements or detailed financial data. This type of announcement fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2021-02-08 English
Appendix 2A - exercise of options 9 pages 251.5KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It details the issuance of securities due to options being exercised or convertible securities being converted. The document is a regulatory announcement related to capital markets activity, specifically the listing of new securities. It is not a financial report, earnings release, or management discussion. It is also not a report publication announcement but a formal application for quotation of securities. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as new securities issuance and quotation applications.
2021-02-07 English
Appendix 2A 9 pages 252.6KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It details the issuance of new securities, specifically shares issued under an employee incentive scheme and other shares issued as consideration for services rendered and rent. The document is regulatory in nature, related to capital market activities, specifically the listing and quotation of new securities. It is not a financial report, earnings release, or management discussion. It is not a proxy, AGM material, or voting results. It is an official announcement related to capital structure changes and securities issuance. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is substantial and contains detailed information about the securities issuance, supporting a high confidence score.
2021-02-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.